Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion type Assertion NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_head.
- NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion description "[NUDT2 immunoreactivity was detected in 78% of DCIS and 63% of IDC, and NUDT2 mRNA level was significantly higher in DCIS or IDC than non-neoplastic breast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_provenance.
- NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion evidence source_evidence_literature NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_provenance.
- NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion SIO_000772 20533549 NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_provenance.
- NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion wasDerivedFrom befree-20140225 NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_provenance.
- NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_assertion wasGeneratedBy ECO_0000203 NP542015.RACFfCQERfJHP8LEQ9ox_D-Z1ywlaKpdpLF6poaN2-6Pk130_provenance.